Coverage
-
October 07, 2013
A New Jersey federal judge on Monday refused to dismiss claims against Sun Pharmaceuticals Ltd. in a patent suit over Sun's generic version of Cephalon Inc.'s anti-epilepsy drug, holding that Cephalon's complaint sufficiently claims willful infringement.
3 other articles on this case.
View all »